CME Group (CME): Rep. Gilbert Ray Cisneros Jr. (CA31) disclosed a purchase $1K–$15K
Rep. Gilbert Ray Cisneros Jr. (CA31) disclosed a purchase of CME Group in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 35 days
- Disclosure lag
- Traded
- Jan 9, 2026
- Disclosed
- Feb 13, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 13, 2025CongressDisclosed partial sale of CME — reported range $1,001 - $15,000
- Nov 20, 2025Insider · 1 personInsiders: 2 sales (~$2.0M)
- Dec 4, 2025Government · Federal Register noticeCME Securities Clearing, Inc.; Order Granting an Application for Registration as a Clearing Agency Under Section 17A of the Securities Exchange Act of 1934
- Dec 11, 2025Insider · 1 personInsiders: 2 sales (~$6.7M)
- Dec 18, 2025CongressDisclosed sale of CME — reported range $1,001 - $15,000
- Jan 9, 2026 · this disclosureCongressDisclosed purchase of CME — reported range $1,001 - $15,000
What came next
- Feb 4, 2026Company filing · Form 8-K · ResultsReported its results
- Feb 6, 2026InsiderDirector sold ~$224K of CME shares in the open market
- Feb 12, 2026Government · Federal Register noticeNotice of an Application of the Chicago Mercantile Exchange Inc. for an Exemption Pursuant to Section 36 of the Securities Exchange Act of 1934 and Request for Comment in Connection With the Opening Price Settlement Requirements of Rule 6h-1(b) Under the Securities Exchange Act of 1934 for Certain Cash-Settled Security Futures
- Feb 20, 2026InsiderDirector sold ~$92K of CME shares in the open market
- Feb 23, 2026InsiderDirector sold ~$1.3M of CME shares in the open market
- Mar 5, 20265% stakeThe Vanguard Group reported a passive stake (13G) of 10.1%
- Mar 6, 2026InsiderDirector sold ~$320K of CME shares in the open market
- Mar 12, 2026Insider · Their largest sale since 2013Officer sold ~$1.59M of CME shares in the open market
- Mar 17, 2026InsiderOfficer sold ~$1.03M of CME shares in the open market
- Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Apr 22, 2026Company filing · Form 8-K · ResultsReported its results
- Apr 22, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
- Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for CME Group
For CME Group, OQRO holds 16 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CME page.
Other recent filings by Rep. Gilbert Ray Cisneros Jr. (CA31)
- House Clerk periodic transaction report at Alexandria Real Estate Equities (ARE)Nov 10, 2026
- House Clerk periodic transaction report at Alliant Energy (LNT)Nov 10, 2026
- House Clerk periodic transaction report at AppLovin (APP)Nov 10, 2026
- House Clerk periodic transaction report at AppLovin (APP)Nov 10, 2026
- House Clerk periodic transaction report at Argenx (ARGX)Nov 10, 2026
The full history of Rep. Gilbert Ray Cisneros Jr. (CA31) is on the profile page.
How this filing works
Explore the data
Other disclosures at CME Group
- SEC Form 13F-HRNov 13, 2026
- SEC Form 4Nov 10, 2026
- SEC Form 144Nov 9, 2026
- SEC Form 4Nov 3, 2026
- SEC Form 4Nov 3, 2026
- SEC Form 144Nov 2, 2026
Everything OQRO holds on this company is on its CME page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
